Page 1 in Annual Report 2001

Active Biotech focuses on developing pharmaceuticals for medical fields in which the immune defence system plays a central role. Our pharmaceutical development is based on our specialist know-how in the field of immunology. We possess a unique infrastruc ture that includes highly experienced researchers who combine cutting edge expertise with efficient project work focusing on clearly defined targets. Ou portfolio includes innovative substances that modulate the human immune system. We have made most progress in developing products designed to treat multiple sclerosis, as well as lung, renal and pancreatic cancer. In order to spread our risks and costs, and to optimise both time to market and market efficiency, we need collaboration partners. These are primarily major pharmaceutical and biotech companies.

  Page 2 - 2 The year in brief. Focus on pharmaceuticals Following the sale of the vaccine  
Annual Report 2000
Annual Report 2002
Annual Report 2003
Annual Report 2004
Annual Report 2005
Annual Report 2006
Annual Report 2007
Annual Report 2008
Annual Report 2009
Annual Report 2010
Annual Report 2011
Annual Report 2012
To read this myPaper publication you need to have JavaScript activated in your web browser. You also need to have at least Flash Version 6 installed.